Renowned Physician-Scientist Brian S. Kim Joins Northwell as First Chief Biotechnology Officer

Renowned Physician-Scientist Brian S. Kim Joins Northwell as First Chief Biotechnology Officer

Building on its legacy as the global pioneer in bioelectronic medicine, The Feinstein Institutes for Medical Research, the research home of Northwell Health, today announced the appointment of Brian S. Kim, MD, MTR, as vice president and chief biotechnology officer at Northwell and head of intellectual asset management at the Feinstein Institutes. Dr. Kim will also serve as the inaugural Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology and professor in the Institute of Bioelectronic Medicine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706981419/en/

Brian S. Kim, MD, MTR, has been named the vice president and chief biotechnology officer at Northwell and head of intellectual asset management at the Feinstein Institutes for Medical Research and the inaugural Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology and professor in the Institute of Bioelectronic Medicine.

A leading dermatologist and physician-scientist, Dr. Kim joins the Feinstein Institutes from the Icahn School of Medicine at Mount Sinai. He has authored more than 190 peer-reviewed publications in leading journals, including Cell, Nature, Science, New England Journal of Medicine and JAMA. He has been continuously funded by the National Institutes of Health since 2011 and leads the Allen Discovery Center for Neuroimmune Interactions, a $10 million multi-institutional center funded by Allen Family Philanthropies.